Document Type : Original Article

Authors

1 Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Department of Nutrition, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran

10.30476/jhsss.2023.99118.1783

Abstract

Background: Metabolic syndrome (MetS) is identified by an accumulation of signs of a metabolic disorder and has become a growing problem in recent years due to its major public health risks. Therefore, this study aimed to assess the prevalence of MetS and its components based on six definitions.
Methods: In this cross-sectional study, 8596 individuals (2966 males and 5630 females) aged 35-70 years were recruited from the Hoveyzeh Cohort Center from May 2016 to August 2018. The diagnostic criteria proposed by the Joint Interim Statement (JIS), the Regional JIS (RJIS), the American Heart Association/ National Heart, Lung, and Blood Institute (AHA/NHLBI), the International Diabetes Federation (IDF), the Regional IDF (RIDF), and Adult Treatment Panel III (ATP III) were used.
Results: The prevalence of MetS was 40.7% (ATP III), 47.3% (IDF), 40.8% (RIDF), 44.2% (AHA/NHLBI), 48.9% (JIS), and 44.7% (RJIS). Overall, males and females showed a higher prevalence of MetS based on the JIS criteria. Based on gender, the prevalence of MetS was higher in women than in men according to all six definitions. The most common component for all deinitions was TGs domain. Also, all four MetS components were higher in people living in urban areas than in those living in rural areas.
Conclusion: The results of this study suggest that a higher prevalence of MetS is related to the JIS definition; this may also indicate the importance of assessing MetS based on this definition in clinical practice in the southern Iranian population.

Highlights

Seyed Mohammad Bahrainian  (Google Scholar)

Leila Moradi (Google Scholar)

Keywords

  1. Shahbazian H, Latifi SM,  Jalali MT,  Shahbazian H,  Amani R, Abdolrasool Nikhoo et al. Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diabetes Metabolic Disorder.2013; 12(1):11. doi: 1186/2251-6581-12-11. PMID: 23497506. PMCID: PMC3598198.
  2. Haung Y, Zhang L, Wang Z, Wang x, Chen Z, Shao L et al. The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012-2015. BMC Public Health 2022; 22(1) 1869:1-11. doi: 10.1186/s12889-022-14263-w; PMID: 36207719; PMCID: PMC9540728.
  3. Zabetian A, Hadaegh F,  Azizi Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.Diabetes Res Clin Pract 2007;77(2)251-7. doi: 10.1016/j.diabres.2006.12.001; PMID: 17234299.
  4. Tan MC, Chuan Ng O, Wong TW, Joseph A, Chan YM, Heja AR. Prevalence of metabolic syndrome in type 2 diabetic patients: A comparative study using WHO, NCEP ATP III, IDF and Harmonized definition. Health 2013;50(10):1689-1696. doi: 4236/health.2013.510227.
  5. do Vale Moreira NC,  Hussain A,  Bhowmik B, Ibrahimu Mdala I Siddiquee TVirgínia Oliveira Fernandes VO, et al. Prevalence of Metabolic Syndrome by different definitions, and its association with type 2 diabetes, pre-diabetes, and cardiovascular disease risk in Brazil. Diabetes Metab Syndr. 2020 ;14(5):1217-1224. doi: 1016/j.dsx.2020.05.043; PMID: 32682310.
  6. Biadgo B, Melak T, Ambachew S, Baynes HW, Limenih MA, Jaleta KN et al. The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018; 28(5): 645–654. doi: 4314/ejhs.v28i5.16. PMID: 30607080; PMCID: PMC6308785.
  7. Grundy SM, Bewer HB, Cleeman JI, Smith SC, Lenfant C, American Heart AssociationNational Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109(3):433-8. doi: 10.1161/01.CIR.0000111245.75752.C6. PMID: 14744958.
  8. Esmailzadehha N,  Ziaee A, Kazemifar AM, Ghorbani A, Oveisi Prevalence of metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran: a comparative analysis of six definitions Endocr Regul2013;47(3):111-20. doi: 10.4149/endo_2013_03_111; PMID: 23889480.
  9. Mammadova A,  Isikhan SY, Acikgoz A,  Yildiz Prevalence of Metabolic Syndrome and Its Relation to Physical Activity and Nutrition in Azerbaijan. Metab Syndr Relat Disord 2019;17(3):160-166. doi: 10.1089/met.2018.0096; PMID: 30620234.
  10. Nikbakht HA, Rezaianzadeh A, Seif M, Ghaem H. Factor Analysis of Metabolic Syndrome Components in a Population-Based Study in the South of Iran (PERSIAN Kharameh Cohort Study). Iran J Public Health 2021;50(9):1863-1871. doi: 10.18502/ijph.v50i9.7059; PMID: 34722382; PMCID: PMC8542825.
  11. Cheraghian B, Hashemi SJ, Hossein SA,  Poustchi H, Rahimi Z,  Sarvandian S, et al. Cohort profile: The Hoveyzeh Cohort Study (HCS): A prospective population-based study on non-communicable diseases in an Arab community of Southwest Iran Med J Islam Repub Iran 2020 21:34:141. doi: 10.34171/mjiri.34.141;PMID: 33437737; PMCID: PMC7787022.
  12. Tabatabaei-Malazy  O, Saeedi Moghaddam S,  Rezaei N , Sheidaei  A,  Hajipour MJ , Negar Mahmoudi  N, et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions. PLoS One 2021;16(3):e0241926. doi: 1371/journal.pone.0241926; PMID: 33657130; PMCID: PMC7928520.
  13. Saklayen The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep 2018;20(2):12. doi: 10.1007/s11906-018-0812-z; PMID: 29480368; PMCID: PMC5866840.
  14. DelavariA  Forouzanfar MH, Alikhani S, Sharifian A, KelishadiFirst nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care2009;32(6):1092-7. doi: 10.2337/dc08-1800; PMID: 19279302; PMCID: PMC2681035.
  15. Mohd Zainuddin LR , Isa N,  Wan Muda WM,  Mohamed The prevalence of metabolic syndrome according to various definitions and hypertriglyceridemic-waist in malaysian adults. Int J Prev Med. 2011;2(4):229-37. PMID: 22174962; PMCID: PMC3237265.
  16. Kazaz  I,  Angin E,  Kabaran S,  İyigün G,  Kirmizigil B,  Malkoç Evaluation of the physical activity level, nutrition quality, and depression in patients with metabolic syndrome: Comparative study.Medicine (Baltimore) 2018;97(18):e0485. doi: 10.1097/MD.0000000000010485; PMID: 29718839: PMCID: PMC6392583.
  17. Stephens CR,  Easton JF ,  Robles-Cabrera  A, Ruben Fossion  R ,   de la Cruz L  , Ricardo Martínez-Tapia R  et al. The Impact of Education and Age on Metabolic Disorders.Front Public Health. 2020:8:180. doi: 10.3389/fpubh.2020.00180; PMID: 32671006;PMCID: PMC7326131.
  18. Okafor Ch I. The metabolic syndrome in Africa: Current trends. Indian J Endocrinol Metab.2012; 16(1): 56–66. doi: 4103/2230-8210.91191.
  19. Osei-Yeboah J,  Owiredu  WKBA,   Norgbe  GK,  Yao Lokpo S, Gyamfi J,   Alote Allotey 1 et al. The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. Int J Chronic Dis. 2017:2017:8765804. doi: 1155/2017/8765804; PMID: 28293668; PMCID: PMC5331170.
  20. Wu Sh,  Fisher-Hoch Sp,  Belinda Reininger B,  McCormick JB. Recommended Levels of Physical Activity Are Associated with Reduced Risk of the Metabolic Syndrome in Mexican-Americans. PLoS One. 2016; 11(4): e0152896. doi: 10.1371/journal.pone.0152896; PMCID: PMC4824434; PMID: 27054324.
  21. Sundarakumar  JS,   Stezin A,  Menesgere A   Ravindranath V; SANSCOG and TLSA Collaborators.Rural-urban and gender differences in metabolic syndrome in the aging population from southern India: Two parallel, prospective cohort studies. doi: 10.1016/j.eclinm.2022.101395; PMID: 35497067; PMCID: PMC9044001.
  22. Weng  X, Liu Y,  Ma J,  Wang W,  Yang G,  Caballero B. An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr2007;10(2):131-6. doi: 10.1017/S1368980007226023; PMID: 17261221.